{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:31:52Z","timestamp":1761093112823,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.urolonc.2020.03.030","type":"journal-article","created":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T19:00:47Z","timestamp":1588618847000},"page":"685.e17-685.e25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The expression of urokinase-type plasminogen activator system in upper tract urothelial carcinoma and its prognostic value after radical nephroureterectomy"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6603-6319","authenticated-orcid":false,"given":"Mohammad","family":"Abufaraj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7194-5982","authenticated-orcid":false,"given":"Shoji","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Haitel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6116-543X","authenticated-orcid":false,"given":"Takihero","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3965-3071","authenticated-orcid":false,"given":"Ula","family":"Isleem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"D'Andrea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8443-8453","authenticated-orcid":false,"given":"Francesco","family":"Soria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6147-6569","authenticated-orcid":false,"given":"Keiichiro","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Rink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karim","family":"Bensalah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgan","family":"Roupr\u00eat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vitaly","family":"Margulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Briganti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre I","family":"Karakiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahrokh F.","family":"Shariat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.urolonc.2020.03.030_bib0001","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.eururo.2017.07.036","article-title":"European association of urology guidelines on upper urinary tract urothelial carcinoma: 2017 update","volume":"73","author":"Roupr\u00eat","year":"2018","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.urolonc.2020.03.030_bib0002","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1464-410X.2008.08003.x","article-title":"Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi\u2010institutional analysis of 1363 patients","volume":"103","author":"Remzi","year":"2009","journal-title":"BJU Int"},{"issue":"3","key":"10.1016\/j.urolonc.2020.03.030_bib0003","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.canep.2013.02.002","article-title":"Incidence, survival and mortality rates of stage-specific bladder cancer in United States: a trend analysis","volume":"37","author":"Abdollah","year":"2013","journal-title":"Cancer Epidemiol"},{"issue":"4","key":"10.1016\/j.urolonc.2020.03.030_bib0004","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.eururo.2017.09.030","article-title":"The role of surgery in metastatic bladder cancer: a systematic review","volume":"73","author":"Abufaraj","year":"2018","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2020.03.030_bib0005","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1464-410X.2011.10288.x","article-title":"Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle\u2010invasive and non\u2010organ confined disease in patients with upper tract urothelial carcinoma","volume":"109","author":"Favaretto","year":"2012","journal-title":"BJU Int"},{"issue":"4","key":"10.1016\/j.urolonc.2020.03.030_bib0006","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.eururo.2010.07.003","article-title":"The effect of tumor location on prognosis in patients treated with radical nephroureterectomy at Memorial Sloan-Kettering Cancer Center","volume":"58","author":"Favaretto","year":"2010","journal-title":"Eur Urol"},{"issue":"7","key":"10.1016\/j.urolonc.2020.03.030_bib0007","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s00345-016-1968-2","article-title":"Prognostic role of expression of N-cadherin in patients with upper tract urothelial carcinoma: a multi-institutional study","volume":"35","author":"Abufaraj","year":"2017","journal-title":"World J Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2020.03.030_bib0008","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00345-016-1835-1","article-title":"Prognostic role of decreased E-cadherin expression in patients with upper tract urothelial carcinoma: a multi-institutional study","volume":"35","author":"Favaretto","year":"2017","journal-title":"World J Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2020.03.030_bib0009","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.eururo.2012.02.030","article-title":"Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature","volume":"62","author":"Lughezzani","year":"2012","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2020.03.030_bib0010","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.juro.2013.07.012","article-title":"Prospective analysis of Ki-67 as an independent predictor of oncologic outcomes in patients with high grade upper tract urothelial carcinoma","volume":"191","author":"Krabbe","year":"2014","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2020.03.030_bib0011","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.urolonc.2010.02.011","article-title":"Statistical consideration for clinical biomarker research in bladder cancer","volume":"28","author":"Shariat","year":"2010","journal-title":"Urol Oncol"},{"issue":"5","key":"10.1016\/j.urolonc.2020.03.030_bib0012","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/med.21308","article-title":"Involvement of urokinase\u2010type plasminogen activator system in cancer: an overview","volume":"34","author":"Mekkawy","year":"2014","journal-title":"Med Res Rev"},{"issue":"9","key":"10.1016\/j.urolonc.2020.03.030_bib0013","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1200\/JCO.2004.09.142","article-title":"Association of preoperative plasma levels of vascular endothelial growth factor and soluble vascular cell adhesion molecule-1 with lymph node status and biochemical progression after radical prostatectomy","volume":"22","author":"Shariat","year":"2004","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.urolonc.2020.03.030_bib0014","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1200\/JCO.2004.09.142","article-title":"Association of preoperative plasma levels of vascular endothelial growth factor and soluble vascular cell adhesion molecule-1 with lymph node status and biochemical progression after radical prostatectomy","volume":"22","author":"Shariat","year":"2004","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.urolonc.2020.03.030_bib0015","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.eururo.2008.06.054","article-title":"Predictive value of the differential expression of the urokinase plasminogen activation axis in radical prostatectomy patients","volume":"55","author":"Gupta","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2020.03.030_bib0016","series-title":"Urologic oncology: seminars and original investigations","article-title":"Prognostic role of the urokinase plasminogen activator (uPA) system in patients with nonmuscle invasive bladder cancer","author":"Iwata","year":"2019"},{"issue":"sup1","key":"10.1016\/j.urolonc.2020.03.030_bib0017","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3109\/0284186X.2010.542174","article-title":"Tumor markers in prostate cancer I: blood-based markers","volume":"50","author":"Shariat","year":"2011","journal-title":"Acta Oncol (Madr)"},{"issue":"5","key":"10.1016\/j.urolonc.2020.03.030_bib0018","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0090-4295(02)02522-0","article-title":"Association of plasma urokinase-type plasminogen activator and its receptor with clinical outcome in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder","volume":"61","author":"Shariat","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2020.03.030_bib0019","series-title":"Urologic oncology: seminars and original investigations","article-title":"Prognostic role of the urokinase plasminogen activator (uPA) system in patients with nonmuscle invasive bladder cancer","author":"Iwata","year":"2019"},{"issue":"1","key":"10.1016\/j.urolonc.2020.03.030_bib0020","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0090-4295(99)80378-1","article-title":"Prognostic value of urokinase-type plasminogen activator in patients with superficial bladder cancer","volume":"47","author":"Hasui","year":"1996","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.urolonc.2020.03.030_bib0021","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/(SICI)1097-0142(19960801)78:3<487::AID-CNCR16>3.0.CO;2-V","article-title":"Clinical relevance of urokinase plasminogen activator, its receptor, and its inhibitor in patients with renal cell carcinoma","volume":"78","author":"Hofmann","year":"1996","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.urolonc.2020.03.030_bib0022","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1186\/1471-2407-14-974","article-title":"Prognostic impact of urokinase-type plasminogen activator system components in clear cell renal cell carcinoma patients without distant metastasis","volume":"14","author":"Fuessel","year":"2014","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.urolonc.2020.03.030_bib0023","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/(SICI)1097-0142(19980215)82:4<724::AID-CNCR16>3.0.CO;2-#","article-title":"Urokinase\u2010type plasminogen activator, its inhibitor, and its receptor in patients with upper urinary tract carcinoma","volume":"82","author":"Nakanishi","year":"1998","journal-title":"Cancer"},{"year":"2011","series-title":"TNM classification of malignant tumours","author":"Sobin","key":"10.1016\/j.urolonc.2020.03.030_bib0024"},{"issue":"5","key":"10.1016\/j.urolonc.2020.03.030_bib0025","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/ijc.10426","article-title":"Expression of UPA and UPAR is associated with the clinical course of urinary bladder neoplasms","volume":"99","author":"Seddighzadeh","year":"2002","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.urolonc.2020.03.030_bib0026","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/01.ju.0000165150.46006.92","article-title":"Expression of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and plasminogen activator inhibitors in patients with renal cell carcinoma: correlation with tumor associated macrophage and prognosis","volume":"174","author":"Ohba","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2020.03.030_bib0027","article-title":"Diagnostic performance of multidetector computed tomographic (MDCTU) in upper tract urothelial carcinoma (UTUC): a systematic review and meta-analysis","author":"Janisch","year":"2019","journal-title":"World J Urol"},{"issue":"5","key":"10.1016\/j.urolonc.2020.03.030_bib0028","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/j.juro.2012.10.057","article-title":"Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized postoperative nomogram using decision curve analysis","volume":"189","author":"Roupr\u00eat","year":"2013","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2020.03.030_bib0029","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.eururo.2012.01.021","article-title":"Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma","volume":"61","author":"Cha","year":"2012","journal-title":"Eur Urol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143920301368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143920301368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:18:46Z","timestamp":1761041926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143920301368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S1078143920301368"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2020.03.030","relation":{},"ISSN":["1078-1439"],"issn-type":[{"type":"print","value":"1078-1439"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The expression of urokinase-type plasminogen activator system in upper tract urothelial carcinoma and its prognostic value after radical nephroureterectomy","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2020.03.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}